{
    "organizations": [],
    "uuid": "0b6b5ac53084078e9a18194fe4e6f52cf1ad7c69",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indivior-says-filed-new-drug-submi/brief-indivior-says-filed-new-drug-submission-with-health-canada-for-sublocade-injection-idUSFWN1RJ0M6",
    "ord_in_thread": 0,
    "title": "BRIEF-Indivior Says Filed New Drug Submission With Health Canada For Sublocade Injection",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - Indivior PLC:\n* SAYS FILED A NEW DRUG SUBMISSION (NDS) WITH HEALTH CANADAâ€™S THERAPEUTIC DRUGS DIRECTORATE FOR SUBLOCADE INJECTION\n* SAYS IF APPROVED, SUBLOCADE WILL BE MARKETED BY INDIVIOR CANADA LTD Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-20T14:38:00.000+03:00",
    "crawled": "2018-04-21T18:23:12.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "indivior",
        "plc",
        "say",
        "filed",
        "new",
        "drug",
        "submission",
        "nd",
        "health",
        "canada",
        "therapeutic",
        "drug",
        "directorate",
        "sublocade",
        "injection",
        "say",
        "approved",
        "sublocade",
        "marketed",
        "indivior",
        "canada",
        "ltd",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}